Carl LeBel - Feb 18, 2022 Form 4 Insider Report for Frequency Therapeutics, Inc. (FREQ)

Role
Chief Development Officer
Signature
/s/ James P. Abely, Attorney-in-Fact for Carl P. LeBel
Stock symbol
FREQ
Transactions as of
Feb 18, 2022
Transactions value $
-$7,545
Form type
4
Date filed
2/23/2022, 03:36 PM
Previous filing
Feb 18, 2022
Next filing
Jul 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FREQ Common Stock Sale -$3.77K -974 -7.4% $3.87* 12.2K Feb 18, 2022 Direct F1, F2
transaction FREQ Common Stock Sale -$3.77K -1.07K -8.77% $3.53* 11.1K Feb 22, 2022 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units and does not represent discretionary trades by the Reporting Person.
F2 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $3.80 to $3.95. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
F3 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $3.40 to $3.73. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.